Breast Neoplasm Malignant Primary

2

Review clinical trials related to Breast Neoplasm Malignant Primary. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

TRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer treatment related cardiac dysfunction (CTRCD). Secondly, the study will evaluate whether novel tools used to improve standardization of recordings as well as automated measurements of central measurements, e.g. ejection fraction (EF) and global longitudinal strain (GLS) can improve the precision of echocardiography in daily clinical practice.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Norwegian University of Science and TechnologyUpdated: Jun 6, 2025Locations: 1
Eligibility criteria

Breast cancer and referral for follow-up to identify potential CTRCD

Not willing or able to consent

Status: Recruiting

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

Breast cancer, the most prevalent malignancy among women globally, is increasing in incidence. While non-metastatic breast cancer requires surgery, determining the optimal extent of resection remains challenging. Inadequate resection margins necessitate reoperation, leading to increased psychological stress, costs, and potentially compromised cosmetic outcomes and prognosis. Accurate preoperative assessment of resection extent is crucial and involves various factors, including imaging studies, physical examinations, tumor molecular subtypes, and intraductal carcinoma components. This prospective observational study aims to identify and integrate multiple predictive factors to enhance surgical planning and minimize reoperation rates in breast cancer patients.

Participants needed: 600
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Incheon St.Mary's HospitalUpdated: Apr 6, 2025Locations: 1Duration: 1 Year
Eligibility criteria

Not listed